- Home
- PTIX vs NDRA Comparison
PTIX vs NDRA Comparison
Compare PTIX & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTIX
- NDRA
- Stock Information
- Founded
- PTIX 1994
- NDRA 2007
- Country
- PTIX United States
- NDRA United States
- Employees
- PTIX N/A
- NDRA N/A
- Industry
- PTIX Biotechnology: Pharmaceutical Preparations
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PTIX Health Care
- NDRA Health Care
- Exchange
- PTIX Nasdaq
- NDRA Nasdaq
- Market Cap
- PTIX 2.0M
- NDRA 2.1M
- IPO Year
- PTIX 2016
- NDRA 2017
- Fundamental
- Price
- PTIX $0.22
- NDRA $3.98
- Analyst Decision
- PTIX
- NDRA Strong Buy
- Analyst Count
- PTIX 0
- NDRA 1
- Target Price
- PTIX N/A
- NDRA $50.00
- AVG Volume (30 Days)
- PTIX 10.5M
- NDRA 355.0K
- Earning Date
- PTIX 05-14-2025
- NDRA 05-13-2025
- Dividend Yield
- PTIX N/A
- NDRA N/A
- EPS Growth
- PTIX N/A
- NDRA N/A
- EPS
- PTIX N/A
- NDRA N/A
- Revenue
- PTIX N/A
- NDRA N/A
- Revenue This Year
- PTIX N/A
- NDRA N/A
- Revenue Next Year
- PTIX N/A
- NDRA N/A
- P/E Ratio
- PTIX N/A
- NDRA N/A
- Revenue Growth
- PTIX N/A
- NDRA N/A
- 52 Week Low
- PTIX $0.18
- NDRA $2.97
- 52 Week High
- PTIX $1.87
- NDRA $665.00
- Technical
- Relative Strength Index (RSI)
- PTIX 42.85
- NDRA 51.65
- Support Level
- PTIX $0.21
- NDRA $3.28
- Resistance Level
- PTIX $0.25
- NDRA $3.98
- Average True Range (ATR)
- PTIX 0.03
- NDRA 0.92
- MACD
- PTIX -0.01
- NDRA 0.02
- Stochastic Oscillator
- PTIX 9.82
- NDRA 31.76
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.